Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kempf-Bielack

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrenceS S Bielack, B Kempf-Bielack, K Winkler
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?S S Bielack, R Erttmann, B Kempf-Bielack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study GroupS S Bielack, B Kempf-Bielack, U Heise, et al.
Bone Marrow Transplantation|July 4, 2001
High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcomaA Sauerbrey, S Bielack, B Kempf-Bielack, et al.
Minerva Pediatrica|April 25, 2013
Controversies in childhood osteosarcomaS Bielack, B Kempf-Bielack, T Von Kalle, et al.
Anticancer Research|February 24, 2001
SV40 sequences in human osteosarcoma of German originS Heinsohn, R B Scholz, B Weber, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2003
Osteosarcoma over the age of fortyR J Grimer, S R Cannon, A M Taminiau, et al.
Klinische Padiatrie|September 3, 1999
[Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients]S Bielack, B Kempf-Bielack, D Schwenzer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Osteosarcoma: relationship of response to preoperative chemotherapy and type of surgery to local recurrenceS S Bielack, B Kempf-Bielack, K Winkler
European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?S S Bielack, R Erttmann, B Kempf-Bielack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study GroupS S Bielack, B Kempf-Bielack, U Heise, et al.
Bone Marrow Transplantation|July 4, 2001
High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcomaA Sauerbrey, S Bielack, B Kempf-Bielack, et al.
Minerva Pediatrica|April 25, 2013
Controversies in childhood osteosarcomaS Bielack, B Kempf-Bielack, T Von Kalle, et al.
Anticancer Research|February 24, 2001
SV40 sequences in human osteosarcoma of German originS Heinsohn, R B Scholz, B Weber, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2003
Osteosarcoma over the age of fortyR J Grimer, S R Cannon, A M Taminiau, et al.
Klinische Padiatrie|September 3, 1999
[Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients]S Bielack, B Kempf-Bielack, D Schwenzer, et al.
Pageof 1